MarketPeel
Insider Trading Intelligence
Pricing
…
AL

Anila Lingamneni

HAE
EVP, CHIEF TECHNOLOGY OFFICER · HAEMONETICS CORP · CIK 0001808414
FILING MIX · LIFETIME45%/55%
BUYS
14
SELLS
17
TOTAL VALUE
$1.71M
COMPANIES
1
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
21,331
AVG SELL PX
$88.63
TRADE KIND
SHOWING 31 / 31
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Anila Lingamneni, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+55.56%-4.65%+0.35%-5.00%-0.08%—
14d9+44.44%-4.52%+0.15%-4.67%-0.46%—
30d9+55.56%-8.11%-2.05%-6.06%-2.98%—
60d9+55.56%-8.11%-0.05%-8.05%-3.70%—
90d9+55.56%-5.29%+3.05%-8.34%-9.56%—
180d9+66.67%-4.37%+5.84%-10.21%-19.62%—
1y9+55.56%-3.85%+10.45%-14.30%-28.75%—
2y9(2 pending)+57.14%+3.80%+28.91%-25.11%-28.75%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HAE · 21,331 shares · as of Jul 12, 2024
07,20614,41321,61928,8252021202220232024SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
FLOW · 14 buys / 17 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HAE
HAEMONETICS CORP
SALE10b5-1
10b5-1 plan
79$90.00$7.1K21,331Jul 12, 2024Jul 15, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE10b5-1
10b5-1 plan
2,136$90.00$192.2K21,410Jul 11, 2024Jul 15, 2024 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
14,140——28,825May 28, 2024May 29, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
5,279$95.73$505.4K23,546May 28, 2024May 29, 2024 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
7,461——7,461May 17, 2024May 21, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
349$95.73$33.4K11,291May 17, 2024May 21, 2024 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
3,394——14,685May 17, 2024May 21, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
318$94.80$30.1K11,640May 16, 2024May 17, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
337$96.49$32.5K11,958May 15, 2024May 17, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE10b5-1
10b5-1 plan
2,305$95.00$219.0K12,295May 6, 2024May 8, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
184$84.88$15.6K14,311Apr 15, 2024Apr 17, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE10b5-1
10b5-1 plan
2,305$90.00$207.4K14,495Sep 11, 2023Sep 13, 2023 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
2,304$83.33$192.0K16,800May 30, 2023Jun 1, 2023 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
1,385$83.34$115.4K19,104May 18, 2023May 19, 2023 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
318$89.21$28.4K20,489May 16, 2023May 17, 2023 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
7,602——7,602May 15, 2023May 17, 2023 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
3,364——20,807May 15, 2023May 17, 2023 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
176$84.78$14.9K17,146Apr 14, 2023Apr 18, 2023 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
1,384$59.10$81.8K17,322May 19, 2022May 23, 2022 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
4,340——18,706May 16, 2022May 18, 2022 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
10,148——10,148May 16, 2022May 18, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
189$56.55$10.7K14,013Apr 18, 2022Apr 19, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
92$55.19$5.1K14,202May 19, 2021May 20, 2021 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
9,564——9,564May 18, 2021May 20, 2021 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
3,535——7,224May 18, 2021May 20, 2021 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
7,070——14,294May 18, 2021May 20, 2021 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP, Chief Technology Officer
170$119.44$20.3K3,444Apr 16, 2021Apr 20, 2021 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
1,209——3,390May 18, 2020May 19, 2020 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
4,092——4,092May 18, 2020May 19, 2020 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
2,181——2,181Apr 15, 2020Apr 17, 2020 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
7,509——7,509Apr 15, 2020Apr 17, 2020 ↗View →
Other insiders · HAE
Loading peer insiders…
About this filer
CIK 0001808414
ROLE
EVP, Chief Technology Officer
PRIMARY
HAE
COMPANIES
1
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001808414DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback